AKERO

Pharmaceutical preparations, namely, compounds for use in the treatment of nonalcoholic steatohepatitis (NASH), fibrosis, inflammatory and autoimmune disorders, cirrhosis, metabolic diseases, cardiovascular diseases, liver fibrosis, kidney fibrosis, lung fibrosis and/or heart fibrosis, retinal and neurodegenerative and other related diseases and disorders; Pharmaceutical preparations for the treatment of fatty liver diseases and disorders and Steatohepatitis and other related diseases and disorders